InvestorsHub Logo
Followers 29
Posts 9421
Boards Moderated 0
Alias Born 04/30/2006

Re: opportunityknocking post# 18610

Thursday, 04/09/2009 11:11:22 PM

Thursday, April 09, 2009 11:11:22 PM

Post# of 30387
Opportunitiy, "There are no better markers to date."

You are extremely out of touch with what is going on. PSA is having problems because it detects TOO MANY cancers. If I remember correctly, for men over 60, about 59% in one study had slow growing prostate cancers. You do not want a test that will just indicate you have cancer cells. You need a test that will tell you if you have fast growing cancer cells. That is what will make RECAF a worthless test. You will in essence have a more worthless test than PSA and causing more problems that PSA ever caused.

There is no test out there that will tell you that you have a fast growing cancer but that is what is needed. That is why RECAF will never be a first line of diagnosis test. I do not think it will ever be a 2nd, 3rd or 4th either. It will just have a difficult time ever developing a market.

If you moved back more than 10 years ago when PSA was first being approved, there might have been a following for RECAF but not today. The medical community today realizes there is a lot more to curing cancer than just early detection.

BTW, you stated you had a medical degree. What is it?


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.